OPTION AGREEMENT - EMPLOYEESOption Agreement • August 5th, 2019 • Arbutus Biopharma Corp • Pharmaceutical preparations • British Columbia
This Option Agreement (the “Agreement”) is entered into between Arbutus Biopharma Corporation (the “Company”) and William H. Collier (the “Optionee”), and is being granted in respect of the Optionee being an employee of Arbutus Biopharma Inc., an Affiliate (“Arbutus”), and confirms that:
OPTION AGREEMENTOption Agreement • August 5th, 2019 • Arbutus Biopharma Corp • Pharmaceutical preparations • British Columbia
This Option Agreement (the “Agreement”) is entered into between Arbutus Biopharma Corporation (the “Company”) and [INSERT name] (the “Optionee”), pursuant to the Arbutus 2016 Omnibus Share and Incentive Plan (the “Plan”) and is being granted in respect of the Optionee being an employee, officer or director of the Company, and confirms that:
PURCHASE AND SALE AGREEMENTPurchase and Sale Agreement • August 5th, 2019 • Arbutus Biopharma Corp • Pharmaceutical preparations • Ontario
This PURCHASE AND SALE AGREEMENT (this “Purchase and Sale Agreement”) dated as of July 2, 2019 is between Arbutus Biopharma Corporation, a company organized under the laws of the Province of British Columbia (the “Seller”), and OCM IP Healthcare Portfolio LP, a limited partnership formed under the laws of the Province of Ontario (the “Purchaser”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 5th, 2019 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
This Executive Employment Agreement (“Agreement”) is made effective as of July 10, 2015 (the “Effective Date”) by and between OnCore Biopharma, Inc. (the “Company”), and Michael J. McElhaugh (the “Executive”) (together the “Parties”).
